Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000498182> ?p ?o ?g. }
- W2000498182 endingPage "648" @default.
- W2000498182 startingPage "642" @default.
- W2000498182 abstract "Study Objectives. To determine the incidence of Clostridium difficile infection (CDI) at one community hospital by identifying patients with stool samples positive for C. difficile toxin A or B, and to compare the incidence with a 2008 national estimate; and to determine which patient characteristics and concomitant antimicrobial and acid-suppression drugs are risk factors for the development of CDI. Design. Retrospective, single-center, medical record review. Setting. 350-bed community hospital. Patients. A total of 11,010 admissions between January 1, 2009, and December 31, 2009; 115 of these patients had stool samples positive for C. difficile toxin A or B. Measurements and Main Results. All C. difficile toxin A and B enzyme immunoassay tests were performed by a central laboratory. The incidence of CDI was 10.4 cases/1000 patient admissions, which was significantly lower than the overall incidence reported in a 2008 national survey of 13.1 CDI cases/1000 patient admissions (p=0.021). Demographic and clinical data of the patients with CDI were collected by using electronic medical records. Patients were more likely to be elderly and female, and to have developed CDI during hospitalization. Of the 115 patients, 95 (82.6%) received acid-suppression therapy and 91 (79.1%) received antimicrobials. Of the patients receiving acid-suppression therapy, 72 (75.8%) received a proton pump inhibitor during their hospitalization, and 49 (51.6%) received both a proton pump inhibitor and an antibiotic. The most frequently used antibiotics in this population were fluoroquinolones, cephalosporins, and carbapenems, with a significantly larger proportion of patients who received carbapenems developing CDI compared with the other classes of antibiotics (p<0.05 for both comparisons). Patients receiving antimicrobial and acid-suppression therapy were more likely to develop CDI than those who did not receive these drugs. Conclusion. The incidence of CDI in 2009 at one community hospital was significantly lower than a 2008 national estimate. Antimicrobial and acid-suppression therapies—in particular, combinations of fluoroquinolones, cephalosporins, carbapenems, and proton pump inhibitors—were found to be risk factors for the development of CDIs in hospitalized patients." @default.
- W2000498182 created "2016-06-24" @default.
- W2000498182 creator A5038724803 @default.
- W2000498182 creator A5061887757 @default.
- W2000498182 date "2011-07-01" @default.
- W2000498182 modified "2023-09-26" @default.
- W2000498182 title "Incidence of<i>Clostridium difficile</i>Infections in Patients Receiving Antimicrobial and Acid-Suppression Therapy" @default.
- W2000498182 cites W1915769571 @default.
- W2000498182 cites W1965640141 @default.
- W2000498182 cites W1984472487 @default.
- W2000498182 cites W1992127020 @default.
- W2000498182 cites W1994193704 @default.
- W2000498182 cites W2017665239 @default.
- W2000498182 cites W2025259807 @default.
- W2000498182 cites W2047080798 @default.
- W2000498182 cites W2065777365 @default.
- W2000498182 cites W2089995592 @default.
- W2000498182 cites W2096454911 @default.
- W2000498182 cites W2116671076 @default.
- W2000498182 cites W2120005441 @default.
- W2000498182 cites W2125756825 @default.
- W2000498182 cites W2134665827 @default.
- W2000498182 cites W2149675013 @default.
- W2000498182 cites W2166660180 @default.
- W2000498182 cites W2171405304 @default.
- W2000498182 cites W2277430674 @default.
- W2000498182 cites W4243613018 @default.
- W2000498182 doi "https://doi.org/10.1592/phco.31.7.642" @default.
- W2000498182 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21923450" @default.
- W2000498182 hasPublicationYear "2011" @default.
- W2000498182 type Work @default.
- W2000498182 sameAs 2000498182 @default.
- W2000498182 citedByCount "26" @default.
- W2000498182 countsByYear W20004981822012 @default.
- W2000498182 countsByYear W20004981822013 @default.
- W2000498182 countsByYear W20004981822014 @default.
- W2000498182 countsByYear W20004981822015 @default.
- W2000498182 countsByYear W20004981822016 @default.
- W2000498182 countsByYear W20004981822017 @default.
- W2000498182 countsByYear W20004981822018 @default.
- W2000498182 countsByYear W20004981822019 @default.
- W2000498182 countsByYear W20004981822020 @default.
- W2000498182 countsByYear W20004981822021 @default.
- W2000498182 countsByYear W20004981822022 @default.
- W2000498182 crossrefType "journal-article" @default.
- W2000498182 hasAuthorship W2000498182A5038724803 @default.
- W2000498182 hasAuthorship W2000498182A5061887757 @default.
- W2000498182 hasConcept C120665830 @default.
- W2000498182 hasConcept C121332964 @default.
- W2000498182 hasConcept C126322002 @default.
- W2000498182 hasConcept C167135981 @default.
- W2000498182 hasConcept C195910791 @default.
- W2000498182 hasConcept C2779384505 @default.
- W2000498182 hasConcept C2781025758 @default.
- W2000498182 hasConcept C2908647359 @default.
- W2000498182 hasConcept C2994496256 @default.
- W2000498182 hasConcept C4937899 @default.
- W2000498182 hasConcept C501593827 @default.
- W2000498182 hasConcept C61511704 @default.
- W2000498182 hasConcept C64778159 @default.
- W2000498182 hasConcept C71924100 @default.
- W2000498182 hasConcept C86803240 @default.
- W2000498182 hasConcept C89423630 @default.
- W2000498182 hasConcept C99454951 @default.
- W2000498182 hasConceptScore W2000498182C120665830 @default.
- W2000498182 hasConceptScore W2000498182C121332964 @default.
- W2000498182 hasConceptScore W2000498182C126322002 @default.
- W2000498182 hasConceptScore W2000498182C167135981 @default.
- W2000498182 hasConceptScore W2000498182C195910791 @default.
- W2000498182 hasConceptScore W2000498182C2779384505 @default.
- W2000498182 hasConceptScore W2000498182C2781025758 @default.
- W2000498182 hasConceptScore W2000498182C2908647359 @default.
- W2000498182 hasConceptScore W2000498182C2994496256 @default.
- W2000498182 hasConceptScore W2000498182C4937899 @default.
- W2000498182 hasConceptScore W2000498182C501593827 @default.
- W2000498182 hasConceptScore W2000498182C61511704 @default.
- W2000498182 hasConceptScore W2000498182C64778159 @default.
- W2000498182 hasConceptScore W2000498182C71924100 @default.
- W2000498182 hasConceptScore W2000498182C86803240 @default.
- W2000498182 hasConceptScore W2000498182C89423630 @default.
- W2000498182 hasConceptScore W2000498182C99454951 @default.
- W2000498182 hasIssue "7" @default.
- W2000498182 hasLocation W20004981821 @default.
- W2000498182 hasLocation W20004981822 @default.
- W2000498182 hasOpenAccess W2000498182 @default.
- W2000498182 hasPrimaryLocation W20004981821 @default.
- W2000498182 hasRelatedWork W2001110218 @default.
- W2000498182 hasRelatedWork W2261274981 @default.
- W2000498182 hasRelatedWork W2355946769 @default.
- W2000498182 hasRelatedWork W2372328648 @default.
- W2000498182 hasRelatedWork W2377735766 @default.
- W2000498182 hasRelatedWork W2417593053 @default.
- W2000498182 hasRelatedWork W3155344727 @default.
- W2000498182 hasRelatedWork W4223487070 @default.
- W2000498182 hasRelatedWork W4320036493 @default.
- W2000498182 hasRelatedWork W4322706536 @default.
- W2000498182 hasVolume "31" @default.
- W2000498182 isParatext "false" @default.